Description
A selective, irreversible inhibitor of FAAH (IC50s = 70 and 313 nM for human and rat forms, respectively); active in vivo, blocking FAAH activity in brain and periphery of rats
Formal name: N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-1-piperazinecarboxamide
Synonyms:
Molecular weight: 410.8
CAS: 1346528-50-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids||Research Area|Neuroscience|Pain Research